If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Oncolytic Viruses Medicine & Life Sciences
CTLA-4 Antigen Medicine & Life Sciences
Riluzole Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

  • 1029 Citations
  • 10 h-Index
  • 14 Article
  • 4 Review article
  • 1 Comment/debate
  • 1 Letter

Clinical characterization of colitis arising from anti-PD-1 based therapy

Wang, D. Y., Mooradian, M. J., Kim, D. W., Shah, N. J., Fenton, S. E., Conry, R. M., Mehta, R., Silk, A., Zhou, A., Compton, M. L., Al-Rohil, R. N., Lee, S., Voorhees, A. L., Ha, L., McKee, S., Norrell, J. T., Mehnert, J., Puzanov, I., Sosman, J. A., Chandra, S. & 5 othersGibney, G. T., Rapisuwon, S., Eroglu, Z., Sullivan, R. & Johnson, D. B., Jan 2 2019, In : OncoImmunology. 8, 1, e1524695.

Rutgers, The State University

Research output: Contribution to journalArticle

Colitis
Steroids
Therapeutics
Prednisone
Melanoma
1 Citations

A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

Mehnert, J., Silk, A., Lee, J. H., Dudek, L., Jeong, B. S., Li, J., Schenkel, J. M., Sadimin, E., Kane, M., Lin, H., Shih, W., Zloza, A., Chen, S. & Goydos, J., Jul 1 2018, In : Pigment Cell and Melanoma Research. 31, 4, p. 534-540 7 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Riluzole
Tumors
Melanoma
Pharmacokinetics
Down-Regulation
14 Citations

Immune activation and benefit from avelumab in EBV-positive gastric cancer

Panda, A., Mehnert, J., Hirshfield, K., Riedlinger, G., Damare, S., Saunders, T., Kane, M., Sokol, L., Stein, M., Poplin, E., Rodriguez-Rodriguez, L., Silk, A., Aisner, J., Chan, N., Malhotra, J., Frankel, M., Kaufman, H. L., Ali, S., Ross, J. S., White, E. P. & 2 othersBhanot, G. & Ganesan, S., Mar 1 2018, In : Journal of the National Cancer Institute. 110, 3, p. 316-320 5 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Human Herpesvirus 4
Stomach Neoplasms
Microsatellite Repeats
Neoplasms
Mutation

Phase I trial of ALT-803, a novel recombinant IL15 complex, in patients with advanced solid tumors

Margolin, K., Morishima, C., Velcheti, V., Miller, J. S., Lee, S. M., Silk, A., Holtan, S. G., Lacroix, A. M., Fling, S. P., Kaiser, J. C., Egan, J. O., Jones, M., Rhode, P. R., Rock, A. D., Cheever, M. A., Wong, H. C. & Ernstoff, M. S., Nov 15 2018, In : Clinical Cancer Research. 24, 22, p. 5552-5561 10 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Interleukin-15
Neoplasms
Natural Killer Cells
Melanoma
Lymphocytes
17 Citations

First-in-human clinical trial of oral ONC201 in patients with refractory solid tumors

Stein, M., Bertino, J., Kaufman, H. L., Mayer, T., Moss, R., Silk, A., Chan, N., Malhotra, J., Rodriguez-Rust, L., Aisner, J., Aiken, R., Haffty, B., DiPaola, R. S., Saunders, T., Zloza, A., Damare, S., Beckett, Y., Yu, B., Najmi, S., Gabel, C. & 7 othersDickerson, S., Zheng, L., El-Deiry, W. S., Allen, J. E., Stogniew, M., Oster, W. & Mehnert, J., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4163-4169 7 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Clinical Trials
Neoplasms
Pharmacokinetics
Keratin-18
Endometrial Neoplasms